Response to first-line treatment with immune-checkpoint inhibitors in patients with advanced cutaneous squamous cell carcinoma: a multicenter, retrospective analysis from the German ADOReg registry
Cutaneous squamous cell carcinoma (cSCC) is a common malignancy of the skin and has an overall favorable outcome, except for patients with an advanced stage of the disease. The efficacy of checkpoint inhibitors (CPI) for advanced cSCC has been demonstrated in recent clinical studies, but data from r...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
11 November 2022
|
| In: |
Cancers
Year: 2022, Jahrgang: 14, Heft: 22, Pages: 1-14 |
| ISSN: | 2072-6694 |
| DOI: | 10.3390/cancers14225543 |
| Online-Zugang: | Resolving-System, Volltext: https://doi.org/10.3390/cancers14225543 Verlag, Volltext: https://www.mdpi.com/2072-6694/14/22/5543 
|
| Verfasserangaben: | Maximilian Haist, Henner Stege, Berenice Mareen Lang, Aikaterini Tsochataridou, Martin Salzmann, Peter Mohr, Dirk Schadendorf, Selma Ugurel, Jan-Malte Placke, Michael Weichenthal, Ralf Gutzmer, Ulrike Leiter, Martin Kaatz, Sebastian Haferkamp, Carola Berking, Markus Heppt, Barbara Tschechne, Patrick Schummer, Christoffer Gebhardt, Stephan Grabbe and Carmen Loquai |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1832506339 | ||
| 003 | DE-627 | ||
| 005 | 20251111094735.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230126s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3390/cancers14225543 |2 doi | |
| 035 | |a (DE-627)1832506339 | ||
| 035 | |a (DE-599)KXP1832506339 | ||
| 035 | |a (OCoLC)1389535825 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Haist, Maximilian |d 1994- |e VerfasserIn |0 (DE-588)1238606032 |0 (DE-627)1765990246 |4 aut | |
| 245 | 1 | 0 | |a Response to first-line treatment with immune-checkpoint inhibitors in patients with advanced cutaneous squamous cell carcinoma |b a multicenter, retrospective analysis from the German ADOReg registry |c Maximilian Haist, Henner Stege, Berenice Mareen Lang, Aikaterini Tsochataridou, Martin Salzmann, Peter Mohr, Dirk Schadendorf, Selma Ugurel, Jan-Malte Placke, Michael Weichenthal, Ralf Gutzmer, Ulrike Leiter, Martin Kaatz, Sebastian Haferkamp, Carola Berking, Markus Heppt, Barbara Tschechne, Patrick Schummer, Christoffer Gebhardt, Stephan Grabbe and Carmen Loquai |
| 264 | 1 | |c 11 November 2022 | |
| 300 | |a 14 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 26.01.2023 | ||
| 520 | |a Cutaneous squamous cell carcinoma (cSCC) is a common malignancy of the skin and has an overall favorable outcome, except for patients with an advanced stage of the disease. The efficacy of checkpoint inhibitors (CPI) for advanced cSCC has been demonstrated in recent clinical studies, but data from real-world cohorts and trial-ineligible cSCC patients are limited. We retrospectively investigated patients with advanced cSCC who have been treated with CPI in a first-line setting at eight German skin cancer centers registered within the multicenter registry ADOReg. Clinical outcome parameters including response, progression-free (PFS) and overall survival (OS), time-to-next-treatment (TTNT), and toxicity were analyzed and have been stratified by the individual immune status. | ||
| 650 | 4 | |a advanced cutaneous squamous cell carcinoma | |
| 650 | 4 | |a cemiplimab | |
| 650 | 4 | |a checkpoint inhibitor therapy | |
| 650 | 4 | |a immunosuppression | |
| 650 | 4 | |a real-world data | |
| 650 | 4 | |a response durability | |
| 700 | 1 | |a Stege, Henner |e VerfasserIn |4 aut | |
| 700 | 1 | |a Lang, Berenice Mareen |e VerfasserIn |4 aut | |
| 700 | 1 | |a Tsochataridou, Aikaterini |e VerfasserIn |4 aut | |
| 700 | 1 | |a Salzmann, Martin |d 1993- |e VerfasserIn |0 (DE-588)1193207150 |0 (DE-627)1671866436 |4 aut | |
| 700 | 1 | |a Mohr, Peter |e VerfasserIn |4 aut | |
| 700 | 1 | |a Schadendorf, Dirk |d 1960- |e VerfasserIn |0 (DE-588)11142576X |0 (DE-627)499566076 |0 (DE-576)289702275 |4 aut | |
| 700 | 1 | |a Ugurel, Selma |d 1971- |e VerfasserIn |0 (DE-588)122030923 |0 (DE-627)081693532 |0 (DE-576)293057567 |4 aut | |
| 700 | 1 | |a Placke, Jan-Malte |e VerfasserIn |4 aut | |
| 700 | 1 | |a Weichenthal, Michael |e VerfasserIn |0 (DE-588)140953272 |0 (DE-627)623003848 |0 (DE-576)321514157 |4 aut | |
| 700 | 1 | |a Gutzmer, Ralf |e VerfasserIn |4 aut | |
| 700 | 1 | |a Leiter, Ulrike |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kaatz, Martin |e VerfasserIn |4 aut | |
| 700 | 1 | |a Haferkamp, Sebastian |e VerfasserIn |4 aut | |
| 700 | 1 | |a Berking, Carola |e VerfasserIn |4 aut | |
| 700 | 1 | |a Heppt, Markus V. |d 1987- |e VerfasserIn |0 (DE-588)1072242346 |0 (DE-627)827081111 |0 (DE-576)43371767X |4 aut | |
| 700 | 1 | |a Tschechne, Barbara |e VerfasserIn |4 aut | |
| 700 | 1 | |a Schummer, Patrick |e VerfasserIn |4 aut | |
| 700 | 1 | |a Gebhardt, Christoffer |e VerfasserIn |4 aut | |
| 700 | 1 | |a Grabbe, Stephan |e VerfasserIn |4 aut | |
| 700 | 1 | |a Loquai, Carmen |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Cancers |d Basel : MDPI, 2009 |g 14(2022), 22, Artikel-ID 5543, Seite 1-14 |h Online-Ressource |w (DE-627)614095670 |w (DE-600)2527080-1 |w (DE-576)313958548 |x 2072-6694 |7 nnas |a Response to first-line treatment with immune-checkpoint inhibitors in patients with advanced cutaneous squamous cell carcinoma a multicenter, retrospective analysis from the German ADOReg registry |
| 773 | 1 | 8 | |g volume:14 |g year:2022 |g number:22 |g elocationid:5543 |g pages:1-14 |g extent:14 |a Response to first-line treatment with immune-checkpoint inhibitors in patients with advanced cutaneous squamous cell carcinoma a multicenter, retrospective analysis from the German ADOReg registry |
| 856 | 4 | 0 | |u https://doi.org/10.3390/cancers14225543 |x Resolving-System |x Verlag |3 Volltext |
| 856 | 4 | 0 | |u https://www.mdpi.com/2072-6694/14/22/5543 |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20230126 | ||
| 993 | |a Article | ||
| 994 | |a 2022 | ||
| 998 | |g 122030923 |a Ugurel, Selma |m 122030923:Ugurel, Selma |d 60000 |e 60000PU122030923 |k 0/60000/ |p 8 | ||
| 998 | |g 11142576X |a Schadendorf, Dirk |m 11142576X:Schadendorf, Dirk |d 50000 |e 50000PS11142576X |k 0/50000/ |p 7 | ||
| 998 | |g 1193207150 |a Salzmann, Martin |m 1193207150:Salzmann, Martin |d 910000 |d 911300 |e 910000PS1193207150 |e 911300PS1193207150 |k 0/910000/ |k 1/910000/911300/ |p 5 | ||
| 999 | |a KXP-PPN1832506339 |e 4252183359 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"id":{"eki":["1832506339"],"doi":["10.3390/cancers14225543"]},"recId":"1832506339","name":{"displayForm":["Maximilian Haist, Henner Stege, Berenice Mareen Lang, Aikaterini Tsochataridou, Martin Salzmann, Peter Mohr, Dirk Schadendorf, Selma Ugurel, Jan-Malte Placke, Michael Weichenthal, Ralf Gutzmer, Ulrike Leiter, Martin Kaatz, Sebastian Haferkamp, Carola Berking, Markus Heppt, Barbara Tschechne, Patrick Schummer, Christoffer Gebhardt, Stephan Grabbe and Carmen Loquai"]},"type":{"bibl":"article-journal","media":"Online-Ressource"},"person":[{"family":"Haist","given":"Maximilian","roleDisplay":"VerfasserIn","display":"Haist, Maximilian","role":"aut"},{"family":"Stege","given":"Henner","roleDisplay":"VerfasserIn","display":"Stege, Henner","role":"aut"},{"family":"Lang","roleDisplay":"VerfasserIn","display":"Lang, Berenice Mareen","given":"Berenice Mareen","role":"aut"},{"family":"Tsochataridou","roleDisplay":"VerfasserIn","given":"Aikaterini","display":"Tsochataridou, Aikaterini","role":"aut"},{"family":"Salzmann","display":"Salzmann, Martin","roleDisplay":"VerfasserIn","given":"Martin","role":"aut"},{"role":"aut","roleDisplay":"VerfasserIn","given":"Peter","display":"Mohr, Peter","family":"Mohr"},{"role":"aut","given":"Dirk","roleDisplay":"VerfasserIn","display":"Schadendorf, Dirk","family":"Schadendorf"},{"role":"aut","display":"Ugurel, Selma","roleDisplay":"VerfasserIn","given":"Selma","family":"Ugurel"},{"roleDisplay":"VerfasserIn","display":"Placke, Jan-Malte","given":"Jan-Malte","family":"Placke","role":"aut"},{"role":"aut","family":"Weichenthal","given":"Michael","roleDisplay":"VerfasserIn","display":"Weichenthal, Michael"},{"role":"aut","family":"Gutzmer","display":"Gutzmer, Ralf","roleDisplay":"VerfasserIn","given":"Ralf"},{"given":"Ulrike","roleDisplay":"VerfasserIn","display":"Leiter, Ulrike","family":"Leiter","role":"aut"},{"roleDisplay":"VerfasserIn","display":"Kaatz, Martin","given":"Martin","family":"Kaatz","role":"aut"},{"role":"aut","family":"Haferkamp","roleDisplay":"VerfasserIn","given":"Sebastian","display":"Haferkamp, Sebastian"},{"role":"aut","family":"Berking","roleDisplay":"VerfasserIn","given":"Carola","display":"Berking, Carola"},{"family":"Heppt","display":"Heppt, Markus V.","roleDisplay":"VerfasserIn","given":"Markus V.","role":"aut"},{"family":"Tschechne","roleDisplay":"VerfasserIn","display":"Tschechne, Barbara","given":"Barbara","role":"aut"},{"family":"Schummer","given":"Patrick","roleDisplay":"VerfasserIn","display":"Schummer, Patrick","role":"aut"},{"family":"Gebhardt","display":"Gebhardt, Christoffer","roleDisplay":"VerfasserIn","given":"Christoffer","role":"aut"},{"role":"aut","given":"Stephan","roleDisplay":"VerfasserIn","display":"Grabbe, Stephan","family":"Grabbe"},{"family":"Loquai","given":"Carmen","roleDisplay":"VerfasserIn","display":"Loquai, Carmen","role":"aut"}],"title":[{"title_sort":"Response to first-line treatment with immune-checkpoint inhibitors in patients with advanced cutaneous squamous cell carcinoma","title":"Response to first-line treatment with immune-checkpoint inhibitors in patients with advanced cutaneous squamous cell carcinoma","subtitle":"a multicenter, retrospective analysis from the German ADOReg registry"}],"origin":[{"dateIssuedDisp":"11 November 2022","dateIssuedKey":"2022"}],"note":["Gesehen am 26.01.2023"],"relHost":[{"origin":[{"dateIssuedDisp":"2009-","publisherPlace":"Basel","publisher":"MDPI","dateIssuedKey":"2009"}],"disp":"Response to first-line treatment with immune-checkpoint inhibitors in patients with advanced cutaneous squamous cell carcinoma a multicenter, retrospective analysis from the German ADOReg registryCancers","language":["eng"],"note":["Gesehen am 27.05.2020"],"physDesc":[{"extent":"Online-Ressource"}],"pubHistory":["1.2009 -"],"name":{"displayForm":["Molecular Diversity Preservation International (MDPI)"]},"id":{"zdb":["2527080-1"],"eki":["614095670"],"issn":["2072-6694"]},"recId":"614095670","title":[{"title_sort":"Cancers","title":"Cancers"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"part":{"issue":"22","pages":"1-14","year":"2022","text":"14(2022), 22, Artikel-ID 5543, Seite 1-14","extent":"14","volume":"14"}}],"physDesc":[{"extent":"14 S."}],"language":["eng"]} | ||
| SRT | |a HAISTMAXIMRESPONSETO1120 | ||